1. GlobeNewsWire.com: Aptinyx initiates two phase 2 studies of NYX-2925 in patients with chronic centralized pain conditions From the article: "NYX-2925 is a novel NMDA receptor modulator that has been granted Fast Track designation by the U.S. Food and Drug Administration. The company expects

1. Prohealth.com: Physicians' fibromyalgia protocols I'm pretty sure I've shared this link with you guys at some point over the years, but Prohealth has been recently updating pages on their website so I think it's worth a second share. This page includes fibromyalgia treatment protocols from

1. Global Lyme Alliance: Global Lyme Alliance launches its first observational study on Lyme disease treatment protocol From the article: "[The alliance's] first study will focus on the treatment regimen developed by Joseph Jemsek, M.D., the founder of the Jemsek Specialty Clinic of Washington

1. GlobeNewsWire.com: Aptinyx announces results of phase 2 fibromyalgia study of NYX-2925 have been selected for late-breaking presentation at the American College of Rheumatology annual meeting From the press release:  "'The results from this study are very encouraging based on our previous

1. Fibromyalgia News Today: 2 proteins identified that may play role in underlying mechanisms of fibromyalgia and neuropathic pain, study finds From the article: "Results of the study ... suggest that these proteins could take part in underlying pain mechanisms involved in these disorders.

1. ScienceDaily.com: New test diagnoses Lyme disease within 15 minutes From the article: "...our test could easily be used directly in a doctor’s office, obviating having to send the samples out to a laboratory that needs at least a couple of hours, if not days, to get test

1. UPI.com: Psychedelic drug therapy enters new era with Johns Hopkins center From the article: "Johns Hopkins University researchers plan to use psychedelic drugs to attack some of society's toughest problems at a new research center, including smoking, depression, alcoholism, Alzheimer's